1. k8·凯发天生赢家·一触即发(中国区)官方网站

      EN
      CN JPN

      Margaret LIAOPartner

      Investment and M&A Corporate Operation Project & Infrastructures Construction & Real Estate Intellectual Property Compliance Healthcare & Life Science Civil & Commercial Dispute Resolution Science Technology, Telecommunication & Internet
      Juris Doctor 86-10-65890756 86-10-65176800 Beijing |
      Practice AreasPractice Areas

      Ms. Liao has in-depth practice and research in the fields of transformation of scientific and technological achievements, algorithmic governance, and cross-border investment and M&A. She has provided all-around services in investment and financing, and corporate governance for a number of scientific and technological corporates in the field of AI, new energy, big health and etc..

      In addition, Ms. Liao has extensive experiences in the development and investment of Internet data centers (IDC), industrial parks, and industrial warehousing properties.

      Professional ExperienceProfessional

      Ms. Liao serves a wide range of clients, including but not limited to Swire Properties, Blackstone Group, Goldman Sachs Group, Singapore Government Investment Corporation, China Life Property & Casualty Insurance, China Taiping Life Insurance and Go High Capital among other well-known organizations. With the development of economy and advancement of science and technology, Ms. Liao actively follows up on the cutting-edge legal fields such as artificial intelligence and other hard technology related areas, and provides professional legal services for scientific and technological achievement transformation projects of Peking University, Tsinghua University and other universities.

      Legal Services Related to Technology Companies

      Acting for a start-up company in the field of renewable energy batteries for its financing and corporate compliance.

      Acting for an offshore fund under Ping An Group for its investment in Airdoc, which is a hi-tech medical device company.

      Advising a pharmaceutical start-up project backed by a top university on its whole process of incubation, investment and financing, commercialization, and compliance.

      Acting for a top university background biopharmaceutical startup project (valued at RMB 500 million) on its angel round financing.

      Acting for a large onshore fund for in investment in a large domestic hotel chain group, which holds nearly 5,000 hotels.

      Acting for a major Chinese insurance group in its acquisition of minority shares in a U.S. insurance group through a Cayman Islands-based private equity fund. The deal is worth around US$300 million.

      M&A and Investment

      Acting for Swire Properties for its acquisition of Sino-Ocean Taikoo Li in Chengdu, a 50% interest held by the Sino-Ocean Group. The deal is worth approximately RMB5.55 billion.

      Assisting one of the top Chinese RE companies in its development and investment in a residential project in Malaysia. The deal is worth around RMB10 billion.

      Assisting an U.S. RE fund in the acquisition of an apartment property in Shanghai from a Japanese owner. The deal is worth around RMB2 billion.

      Acting for a U.S. fund in the development and operation of a large residential project in Linyi with a domestic partner. The deal is worth around RMB3 billion.

      Advising a major fund on its contemplated investment in a distressed real estate project in downtown area of Beijing.

      Advising a U.S. RE fund on its contemplated investment in a shopping mall in Haidian, Beijing.

      Acting for a major offshore fund in its investment in the development of a high-end shopping mall in the downtown area of Hangzhou.

      Internet data center (IDC), industrial park, logistics property and other new infrastructure investments

      Advising Hao Yang Cloud Data and Apollo Fund for the acquisition of Baoding No.1 Internet data center (IDC).

      Acting for a leading internet company’s offshore entity in connection with its domestic partner for the development of a large-scale comprehensive science and technology park worth around RMB10 billion.

      Acting for a large domestic fund for contemplated investment into an IDC holding company which owns more than ten IDC projects in Beijing, Shanghai, Guangzhou, Chongqing and Wuhan.

      Acting for a high-profile US fund for investment into multi-phase IDC project in Shanghai. The investment is worth around USD550 million.

      Acting for a Hong Kong listed company for several investments in IDC projects located in Shenzhen, Hebei, Shanghai.

      Acting for one of the internet giants in its tender for several IDC resources located in Tianjin, Zhangjiakou etc.

      Acting for a domestic RE fund for its contemplated acquisition of several IDCs in Beijing and Shanghai.

      Acting for a domestic RE fund in its investment in a distressed assets in Beijing and transforming it into a medical technology industrial park through renovation. The deal is worth around RMB2 billion.

      Acting for a high-profile foreign investor in its share acquisition of four project companies each holding a warehouse real estate project in Wuhan, Kunshan, Nanjing and Hefei respectively. The deal is worth up to around RMB 3 billion.

      Acting for a top US RE fund and its local partner for their share acquisition of a project company which holds a warehouse project in Gu’an Hebei.

      Acting for a high-profile foreign investor in its investment in a large-scale medical industrial park in Shanghai. The investment is worth around RMB1.5 billion.

      Compliance and Fund Use of Insurance Company

      Acting for a large state-owned insurance company in its acquisition of an office building in Beijing at property exchange from another state-owned company. The deal is worth RMB3.6 billion.

      Acting for a top insurance company in its offshore acquisition of a large-scale skilled nursing facility based in U.S. The contemplated deal is worth up to USD 970 million.

      Acting for one of the largest Chinese insurance companies in its contemplated share subscription of a non-banking financial institute. The deal is worth up to RMB 2 billion.

      Assisting one of the top Japanese financial groups in its equity acquisition of a large Sino-foreign J.V. insurance company from a main Australian financial group. The deal is worth RMB 3.7 billion.

      Advising a South Korea insurance group in shareholders disputes with its local partner on a Sino-Korea J.V.’s compliance and corporate governance issues.

      Advising an insurance company in its issuance of new capital to its majority shareholder. The deal is worth around RMB1 billion.

      Advising Ping An, China Life, Bupa, Taikang, CITIC Prudential etc. on daily basis regarding compliance, corporate governance and other legal issues.

      Awards & RecognitionsAwards & Recognitions

      Admitted to the Talent Pool of Beijing Lawyers Association of Foreign-related Lawyers in 2022

      work experienceexperience

      Grandall Law Firm (Beijing), Partner

      Zhonglun Law Firm (Beijing), Senior Associate

      Temple University(Tokyo Campus), Adjunct Professor

      Baker·Mckenzie (Hong Kong), Legal Assistant

      Educationeducation

      Chinese University of Hong Kong, Juris Doctor

      Peking University, Bachelor and Mphil. In History

      Academic TitlesAcademic Titles

      Temple University, Tokyo Campus Adjunct Professor

      Languageslanguage

      Chinese & English

      友情链接: